Searchable abstracts of presentations at key conferences in endocrinology

ea0063p8 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Metabolic and cardiovascular profile of 143 adrenal incidentalomas

Araujo-Castro Marta , Nunez Miguel Sampedro , Ramirez Paola Parra , Lazaro Cristina Robles , Hernandez Martin Cuesta , Marazuela Monica

Objective: To study the differences in the metabolic profile of patients with non-functioning adrenal adenomas (NFA) and autonomous cortisol secretion (ACS).Methods: 143 patients diagnosed of adrenal incidentaloma (AI) between 2010 and 2018 were retrospectively analyzed. AI was defined as an adrenal mass≥1 cm, accidentally discovered by radiologic examination. ACS was confirmed by serum cortisol post-dexamethasone suppression test (Nugent)≥3 ...

ea0041ep423 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Diabetes and glycemic control in acute heart failure: complications, hospital stay and prognosis

Paredes Silvia , Lopes Melina , Ramos-Lopes Margarida , Araujo David , Cardoso Rosa , Monteiro Ana Margarida , Pimentel Teresa , Marques Olinda , Alves Marta

Introduction: Few studies have evaluated the impact of type 2 diabetes on the prognosis of acute heart failure (HF). This study assessed the effect of diabetes and glycemic control on complications, hospital stay and prognosis in patients with acute HF.Methods: Retrospectively, databases of 428 hospitalized patients by acute HF were analyzed, 201 diabetic patients and 227 controls. Statistical analysis was done using SPSS, considering statistical signifi...

ea0035p719 | Neuroendocrinology | ECE2014

Effects of pharmacological blockade of glucocorticoids on energy homeostasis control by liver and pancreas in rats without pineal gland

Rodrigues Sandra Campos , Pantaleao Lucas Carminatti , de Araujo Veras Katherine M. , Amaral Fernanda Gaspar , Anhe Gabriel Forato , Bordin Silvana

In liver, melatonin (Mel) and glucocorticoids (GC) influence the systemic energy homeostasis. Animals without pineal gland present impairment in glycemic control, as in type-2 diabetes. In turn, Mel reduces the GC levels, particularly in nocturnal animals. We aimed to evaluate the influence of Mel, as well as GC receptor blockade by RU486 treatment on hepatic and pancreatic energy metabolism. Male Wistar rats were subjected to surgical removal of pineal and, 25 days after the ...

ea0070aep26 | Adrenal and Cardiovascular Endocrinology | ECE2020

Genetic alterations and clinical features in 16 brazilian patients with pheochromocytomas and paragangliomas

Naliato Erika , Araujo Paula , Soares Paula , Lima Jorge , Lima Vinicius , Wo Julia , Sanchez Mirna , Carvalho Denise , Violante Alice

Introduction: Pheochromocytomasand paragangliomas are tumors derived from chromaffin cells which result from mutations of at least six different genes as autosomal dominant disorders.Aim: To evaluate the existence of correlations between genetic alterations and clinical data in 16 patients with pheochromocytomas and/or paragangliomas.Methods: From 2007 to 2009, 13 patients with pheochromocytoma [3 men, medium age 39 years (14&#8211...

ea0073aep14 | Adrenal and Cardiovascular Endocrinology | ECE2021

Differential phenotype of bilateral macronodular adrenal hyperplasia and other bilateral adrenal lesions with associated subclinical hypercortisolism. Study of 98 patients

Rojano Nuria Bengoa , Maria Fernandez Argüeso , Pascual-Corrales Eider , José I. Botella-Carreter , Araujo-Castro Marta

PurposeTo evaluate the prevalence of bilateral macronodular adrenal hyperplasia (BMAH) in patients with adrenal incidentalomas (AIs) and analyse the differential phenotype of patients with BMAH compared to other bilateral adrenal lesions which do not meet BMAH definition (non-BMAH), with associated possible or confirmed autonomous cortisol secretion (ACS).MethodsRetrospective study of patients with AIs diagno...

ea0073aep499 | Pituitary and Neuroendocrinology | ECE2021

Ectopic cushing’s syndrome: Report of 5 cases from a tertiary care center

Pascual-Corrales Eider , Pinedo Marta Marchan , Maria Fernandez Argüeso , Manuel Luque-Ramírez , Castro Marta Araujo

IntroductionEctopic Cushing’s syndrome (ECS) is a rare entity caused by ACTH secretion by a non-pituitary tumor. The management of these patients is challenging due to its low frequency and limited experienced. The objective of this study was to describe the patients with ECS treated in the Division of Endocrinology at the Ramón y Cajal University Hospital (Madrid, Spain) in the last six years.Methods<p class="abstext...

ea0063p215 | Diabetes, Obesity and Metabolism 1 | ECE2019

Lipodistrophy, a rare disease: ‘If you don’t think about it, you doesn’t diagnose it’

Ortega Rodriguez Pilar , Valverde Lopez ME , Lopez Martin M , Mayorga Roldan E , Perez Rebollo I , Salas Carrasco Pilar , Vilar Araujo D

Introduction: In the geographical area of southern Spain, in the province of Huelva, we have detected prevalent cases of Dunnigan’s partial hereditary lipodystrophy. The genealogy, the suspicion phenotype and the coordination with the Genetics Service and Reference center, have borne fruit, and more and more families are detected in Our Area. The lipodystrophies, in general, are rare diseases that affect the adipose tissue, disappearance of it in different parts of the bo...

ea0063p586 | Diabetes, Obesity and Metabolism 2 | ECE2019

Real-world experience of generalized and partial lipodystrophy patients enrolled in the metreleptin early access program

Cook Keziah , Stears Anna , Araujo-Vilar David , Santini Ferruccio , O'Rahilly Stephen , Ceccarini Giovanni , Tibrewala Shruti , Bradt Pamela , Vigouroux Corinne , Vatier Camille , Savage David B

Objective: To evaluate the real-world experience of patients with generalized (GL) and partial (PL) lipodystrophy initiating treatment with metreleptin as part of an early access program (EAP).Methods: A retrospective data collection was conducted from four countries for patients enrolled in the EAP. A descriptive analysis was performed on selected patient characteristics, baseline organ impairments and complications, and response to metreleptin therapy,...

ea0049ep948 | Pituitary - Clinical | ECE2017

Resistant prolactinomas: Retrospective study of ten cases

Castro Marta Araujo , Garcia Nuria Palacios , Pardo Javier Aller , Lopez Ainhoa Abad , Zarate Virginia Oses , Moreno Laura Mateos , Garcia Javier Estrada

About 10–15% of prolactinomas (P) are resistant to Dopamine agonists (DA). We analyzed retrospectively ten resistant prolactinomas (RP) treated at our center between 1995 and 2014, to identify useful variables to predict DA resistance and its different patterns (biochemical resistance (BR), morphological resistance (MR) or both). BR is defined as the failure to normalize prolactin (PRL) levels with ≥ 2 mg/week of cabergoline (C) for at least 3 months. MR is consider...

ea0041ep338 | Clinical case reports - Thyroid/Others | ECE2016

Diabetes mellitus and ataxia with anti-glutamic acid decarboxylase antibodies

Oliveira Diana , Araujo Rui , Moreno Carolina , Rodrigues Dircea , Guelho Daniela , Vicente Nuno , Cardoso Luis , Martins Diana , Lages Adriana , Ventura Mara , Paiva Sandra , Carrilho Francisco

Introduction: Glutamic acid decarboxylase (GAD65) is expressed by pancreatic beta cells and also by GABA (gamma-aminobutyric acid)-secreting neurons. Cerebellar ataxia associated with anti-GAD65 antibodies (antiGAD Ab) is a rare neurological disorder that frequently coexists with other autoimmune conditions, namely Diabetes Mellitus (DM).Case reports: We describe two cases of ataxia associated with antiGAD Ab. The first case is a 69-year-old obe...